Dr. Varant B. Arzoumanian, MD

Dr. Arzoumanian practices at Baptist Health Medical Center Fort Smith in Fort Smith, Arkansas, part of Baptist Health.

Dr. Arzoumanian's NPI, 1790904027, was assigned on April 25, 2007. Dr. Arzoumanian graduated from St Joseph's University Medical School in 1996. Dr. Arzoumanian holds Arkansas license E5432.

Dr. Arzoumanian's primary practice is Baptist Health Medical Center Fort Smith, at 1001 Towson Avenue, Fort Smith, AR 72901 in Sebastian County. The practice phone is (479) 441-4000.

Dr. Arzoumanian's primary practice is Baptist Health Medical Center Fort Smith in Fort Smith, Arkansas, part of Baptist Health. Dr. Arzoumanian is also affiliated with Mercy Hospital Fort Smith. The medical group on file is Mercy Clinic Fort Smith Communities. Dmand AI also links Dr. Arzoumanian to 3 more hospitals, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arzoumanian practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Arzoumanian's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Arzoumanian is board certified in hematology by the American Board of Internal Medicine. Dr. Arzoumanian is licensed in Arkansas.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Arzoumanian treats.

CMS data shows 3,801 Medicare services from Dr. Arzoumanian across 12 procedure codes in 2024, for 857 Medicare patients. Medicare paid $240,408 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 857 Medicare patients who saw Dr. Arzoumanian in 2024. The largest group is 65 to 74, with 356 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Arzoumanian's median patient age at 72, with 54% women.

In 2024, Dr. Arzoumanian wrote 6,917 Medicare Part D claims for 770 patients. 84% of them were for generic drugs. CMS names the drug for 6,506 of them, across 104 drugs with 11 or more claims each, at $9,259,515 in total drug cost. In 2023, CMS named 6,295 claims across 93 drugs.

Dr. Arzoumanian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Arzoumanian, published from 2006 to 2008. 2006 was the busiest year, with 2. The most frequent topics are Multiple Myeloma, Hematopoietic Stem Cell Transplantation and Monoclonal Gammopathy of Undetermined Significance. Dr. Arzoumanian's most frequent co-authors are Bart Barlogie, MD, Frits Van Rhee, MD and Elias Anaissie, MD.

CMS Open Payments shows 623 general payments to Dr. Arzoumanian from 49 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Pfizer Inc. paid the most, $1,334.

Dr. Arzoumanian graduated from St Joseph's University Medical School in 1996. Dr. Arzoumanian is a member of ASCO.

Dr. Arzoumanian is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.